Literature DB >> 25552355

What the dead can teach the living: systemic nature of heart failure with preserved ejection fraction.

Dalane W Kitzman1, Bharathi Upadhya2, Sujethra Vasu2.   

Abstract

Entities:  

Keywords:  Editorials; aging; autopsy; comorbidity; coronary artery disease; fibrosis; heart failure; hypertrophy; inflammation; left ventricular

Mesh：

Year:  2014        PMID： 25552355      PMCID： PMC4792113          DOI： 10.1161/CIRCULATIONAHA.114.014420

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

1.  Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction.

Authors:  Mark J Haykowsky; Erik J Kouba; Peter H Brubaker; Barbara J Nicklas; Joel Eggebeen; Dalane W Kitzman
Journal:  Am J Cardiol       Date:  2014-01-15       Impact factor: 2.778

2.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.

Authors:  J S Gottdiener; A M Arnold; G P Aurigemma; J F Polak; R P Tracy; D W Kitzman; J M Gardin; J E Rutledge; R C Boineau
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

3.  Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction.

Authors:  Bishnu P Dhakal; Rajeev Malhotra; Ryan M Murphy; Paul P Pappagianopoulos; Aaron L Baggish; Rory B Weiner; Nicholas E Houstis; Aaron S Eisman; Stacyann S Hough; Gregory D Lewis
Journal:  Circ Heart Fail       Date:  2014-10-24       Impact factor: 8.790

4.  Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.

Authors:  Pardeep S Jhund; Brian L Claggett; Adriaan A Voors; Michael R Zile; Milton Packer; Burkert M Pieske; Elisabeth Kraigher-Krainer; Amil M Shah; Margaret F Prescott; Victor Shi; Marty Lefkowitz; John J V McMurray; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2014-10-02       Impact factor: 8.790

5.  Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.

Authors:  Evangelos Oikonomou; Gerasimos Siasos; Marina Zaromitidou; George Hatzis; Konstantinos Mourouzis; Christine Chrysohoou; Konstantinos Zisimos; Savvas Mazaris; Panagiotis Tourikis; Dimitris Athanasiou; Christodoulos Stefanadis; Athanasios G Papavassiliou; Dimitris Tousoulis
Journal:  Atherosclerosis       Date:  2014-12-11       Impact factor: 5.162

6.  Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.

Authors:  Selma F Mohammed; Saad Hussain; Sultan A Mirzoyev; William D Edwards; Joseph J Maleszewski; Margaret M Redfield
Journal:  Circulation       Date:  2014-12-31       Impact factor: 29.690

7.  Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: implications for heart failure with preserved ejection fraction.

Authors:  Mário Santos; Alexander R Opotowsky; Amil M Shah; Julie Tracy; Aaron B Waxman; David M Systrom
Journal:  Circ Heart Fail       Date:  2014-12-30       Impact factor: 8.790

8.  Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction.

Authors:  Dalane W Kitzman; Barbara Nicklas; William E Kraus; Mary F Lyles; Joel Eggebeen; Timothy M Morgan; Mark Haykowsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-21       Impact factor: 4.733

9.  Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiology.

Authors:  Brendan N Putko; Zuocheng Wang; Jennifer Lo; Todd Anderson; Harald Becher; Jason R B Dyck; Zamaneh Kassiri; Gavin Y Oudit
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

10.  Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF.

Authors:  Gaetano M De Ferrari; Anton E Tuinenburg; Stephen Ruble; Josep Brugada; Helmut Klein; Christian Butter; David J Wright; Bernd Schubert; Scott Solomon; Scott Meyer; Kenneth Stein; Agnes Ramuzat; Faiez Zannad
Journal:  Eur J Heart Fail       Date:  2014-05-20       Impact factor: 15.534
View more
  15 in total

1.  Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale.

Authors:  Gordon R Reeves; David J Whellan; Pamela Duncan; Christopher M O'Connor; Amy M Pastva; Joel D Eggebeen; Leigh Ann Hewston; Timothy M Morgan; Shelby D Reed; W Jack Rejeski; Robert J Mentz; Paul B Rosenberg; Dalane W Kitzman
Journal:  Am Heart J       Date:  2016-12-28       Impact factor: 4.749

Review 2.  Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.

Authors:  Bharathi Upadhya; Dalane W Kitzman
Journal:  Am J Cardiovasc Drugs       Date:  2017-08       Impact factor: 3.571

3.  Zooming in on the Microvasculature in Heart Failure With Preserved Ejection Fraction.

Authors:  Selma F Mohammed; David T Majure; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

Review 4.  Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction.

Authors:  Bharathi Upadhya; Mark J Haykowsky; Joel Eggebeen; Dalane W Kitzman
Journal:  Curr Heart Fail Rep       Date:  2015-06

Review 5.  Heart failure with preserved ejection fraction in the elderly: scope of the problem.

Authors:  Bharathi Upadhya; George E Taffet; Che Ping Cheng; Dalane W Kitzman
Journal:  J Mol Cell Cardiol       Date:  2015-03-06       Impact factor: 5.000

Review 6.  Evolution of a Geriatric Syndrome: Pathophysiology and Treatment of Heart Failure with Preserved Ejection Fraction.

Authors:  Bharathi Upadhya; Barbara Pisani; Dalane W Kitzman
Journal:  J Am Geriatr Soc       Date:  2017-11       Impact factor: 5.562

7.  Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.

Authors:  María Valero-Muñoz; Shanpeng Li; Richard M Wilson; Maarten Hulsmans; Tamar Aprahamian; José J Fuster; Matthias Nahrendorf; Philipp E Scherer; Flora Sam
Journal:  Circ Heart Fail       Date:  2016-01       Impact factor: 8.790

8.  Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.

Authors:  Amanda K Verma; Jie-Lena Sun; Adrian Hernandez; John R Teerlink; Phillip J Schulte; Justin Ezekowitz; Adriaan Voors; Randall Starling; Paul Armstrong; Christopher M O'Conner; Robert J Mentz
Journal:  Clin Cardiol       Date:  2018-07-17       Impact factor: 2.882

9.  Hospitalizations and Prognosis in Elderly Patients With Heart Failure and Preserved Ejection Fraction: Time to Treat the Whole Patient.

Authors:  Dalane W Kitzman; Bharthi Upadhya; Gordon Reeves
Journal:  JACC Heart Fail       Date:  2015-05-14       Impact factor: 12.035

Review 10.  Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.

Authors:  Wynn G Hunter; Jacob P Kelly; Robert W McGarrah; William E Kraus; Svati H Shah
Journal:  Curr Heart Fail Rep       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.